Mycobacterium Citations List: March, 2017
Literature Citations
1. In Silico Discovery and in Vitro Activity of Inhibitors against Mycobacterium tuberculosis 7,8-Diaminopelargonic acid Synthase (Mtb BioA). Billones, J.B., M.C. Carrillo, V.G. Organo, J.B. Sy, N.A. Clavio, S.J. Macalino, I.A. Emnacen, A.P. Lee, P.K. Ko, and G.P. Concepcion. Drug Design, Development and Therapy, 2017. 11: p. 563-574. PMID[28280303]. PMCID[PMC5338852].
[PubMed]. TB_03_2017.
2. Novel Pharmacological Activity of Artesunate and Artemisinin: Their Potential as Anti-tubercular Agents. Choi, W.H. Journal of Clinical Medicine, 2017. 6(3): E30. PMID[28287416]. PMCID[PMC5372999].
[PubMed]. TB_03_2017.
3. Activity of Moxifloxacin and Linezolid against Mycobacterium tuberculosis in Combination with Potentiator Drugs Verapamil, Timcodar, Colistin and SQ109. de Knegt, G.J., A. van der Meijden, C.P. de Vogel, R.E. Aarnoutse, and J.E. de Steenwinkel. International Journal of Antimicrobial Agents, 2017. 49(3): p. 302-307. PMID[28162983].
[PubMed]. TB_03_2017.
4. Synthesis and Antitubercular Activity of New Thiazolidinones with Pyrazinyl and Thiazolyl Scaffolds. Dhumal, S.T., A.R. Deshmukh, L.D. Khillare, M. Arkile, D. Sarkar, and R.A. Mane. Journal of Heterocyclic Chemistry, 2017. 54(1): p. 125-130. ISI[000394058900014].
[WOS]. TB_03_2017.
5. Combination Effect of Antituberculosis Drugs and Ethanolic Extract of Selected Medicinal Plants against Multi-drug Resistant Mycobacterium tuberculosis Isolates. Fauziyah, P.N., E.Y. Sukandar, and D.K. Ayuningtyas. Scientia Pharmaceutica, 2017. 85(1): E14. PMID[28335544].
[PubMed]. TB_03_2017.
6. A Novel Benzothiazinethione Analogue SKLB-TB1001 Displays Potent Antimycobacterial Activities in a Series of Murine Models. Gao, C., T.H. Ye, C.T. Peng, Y.J. Shi, X.Y. You, L. Xiong, K. Ran, L.D. Zhang, X.X. Zeng, N.Y. Wang, L.T. Yu, and Y.Q. Wei. Biomedicine & Pharmacotherapy, 2017. 88: p. 603-609. PMID[28142116].
[PubMed]. TB_03_2017.
7. Synthesis and Characterization of New 1-(4-Methylpiperazin-1-yl)-thioureas as Potential Antitubercular Agents. Hearn, M.J., T. Wang, and M.H. Cynamon. Journal of Heterocyclic Chemistry, 2017. 54(1): p. 720-727. ISI[000394058900092].
[WOS]. TB_03_2017.
8. Synthesis, Molecular Docking, Antimycobacterial and Antimicrobial Evaluation of New Pyrrolo[3,2-C]pyridine Mannich Bases. Jose, G., T.H. Suresha Kumara, H.B. Sowmya, D. Sriram, T.N. Guru Row, A.A. Hosamani, S.S. More, B. Janardhan, B.G. Harish, S. Telkar, and Y.S. Ravikumar. European Journal of Medicinal Chemistry, 2017. 131: p. 275-288. PMID[28340368].
[PubMed]. TB_03_2017.
9. Synthesis and Molecular Modeling Studies of Novel Pyrrole Analogs as Antimycobacterial Agents. Joshi, S.D., U.A. More, K. Pansuriya, T.M. Aminabhavi, and A.K. Gadad. Journal of Saudi Chemical Society, 2017. 21(1): p. 42-57. ISI[000396376900006].
[WOS]. TB_03_2017.
10. Evaluation of the Antimycobacterial Activity of Crude Extracts and Solvent Fractions of Selected Ethiopian Medicinal Plants. Kahaliw, W., A. Aseffa, M. Abebe, M. Teferi, and E. Engidawork. BMC Complementary and Alternative Medicine, 2017. 17(143): 9pp. PMID[28274226]. PMCID[PMC5343536].
[PubMed]. TB_03_2017.
11. Anti-mycobacteria Potential and Synergistic Effects of Combined Crude Extracts of Selected Medicinal Plants Used by Bapedi Traditional Healers to Treat Tuberculosis Related Symptoms in Limpopo Province, South Africa. Komape, N.P.M., V.P. Bagla, P. Kabongo-Kayoka, and P. Masoko. BMC Complementary and Alternative Medicine, 2017. 17(128): 13pp. PMID[28235402]. PMCID[PMC5324313].
[PubMed]. TB_03_2017.
12. Naphthalimides Selectively Inhibit the Activity of Bacterial, Replicative DNA Ligases and Display Bactericidal Effects against Tubercle Bacilli. Korycka-Machala, M., M. Nowosielski, A. Kuron, S. Rykowski, A. Olejniczak, M. Hoffmann, and J. Dziadek. Molecules, 2017. 22(1): E154. PMID[28106753].
[PubMed]. TB_03_2017.
13. Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents. Kratky, M., J. Stolarikova, and J. Vinsova. Molecules, 2017. 22(4): E535. PMID[28350331].
[PubMed]. TB_03_2017.
14. Antimicrobial Activity of Rhodanine-3-acetic acid Derivatives. Kratky, M., J. Vinsova, and J. Stolarikova. Bioorganic & Medicinal Chemistry, 2017. 25(6): p. 1839-1845. PMID[28196707].
[PubMed]. TB_03_2017.
15. Antimicrobial Susceptibility and MIC Distribution of 41 Drugs against Clinical Isolates from China and Reference Strains of Nontuberculous Mycobacteria. Li, G., H. Pang, Q. Guo, M. Huang, Y. Tan, C. Li, J. Wei, Y. Xia, Y. Jiang, X. Zhao, H. Liu, L.L. Zhao, Z. Liu, D. Xu, and K. Wan. International Journal of Antimicrobial Agents, 2017. 49(3): p. 364-374. PMID[28131606].
[PubMed]. TB_03_2017.
16. Design, Synthesis, and Biological Evaluation of New 8-Trifluoromethylquinoline Containing Pyrazole-3-carboxamide Derivatives. Nayak, N., J. Ramprasad, and U. Dalimba. Journal of Heterocyclic Chemistry, 2017. 54(1): p. 171-182. ISI[000394058900022].
[WOS]. TB_03_2017.
17. The Discovery of 2-Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to beta-Lactam Antibiotics in a Pattern Distinct from beta-Lactamase Inhibitors. Nguyen, T.V., M.S. Blackledge, E.A. Lindsey, B.M. Minrovic, D.F. Ackart, A.B. Jeon, A. Obregon-Henao, R.J. Melander, R.J. Basaraba, and C. Melander. Angewandte Chemie, 2017. 56(14): p. 3940-3944. PMID[28247991].
[PubMed]. TB_03_2017.
18. Antimicrobial Activity of Lichen Bryoria capillaris and Its Compound Barbatolic acid. Sariozlu, N.Y., M.Y. Cankilic, M. Candan, and T. Tay. Biomedical Research, 2016. 27: p. S419-S423. ISI[000393477900019].
[WOS]. TB_03_2017.
19. 3-Substituted N-benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation. Semelkova, L., O. Jandourek, K. Konecna, P. Paterova, L. Navratilova, F. Trejtnar, V. Kubicek, J. Kunes, M. Dolezal, and J. Zitko. Molecules, 2017. 22(3): E495. PMID[28335571].
[PubMed]. TB_03_2017.
20. Thermal and Photoinduced Copper-promoted C-Se Bond Formation: Synthesis of 2-Alkyl-1,2-benzisoselenazol-3(2H)-ones and Evaluation against Mycobacterium tuberculosis. Thanna, S., C.M. Goins, S.E. Knudson, R.A. Slayden, D.R. Ronning, and S.J. Sucheck. The Journal of Organic Chemistry, 2017. 82(7): p. 3844-3854. PMID[28273423].
[PubMed]. TB_03_2017.
21. Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis Proteasome. Totaro, K.A., D. Barthelme, P.T. Simpson, X.J. Jiang, G. Lin, C.F. Nathan, R.T. Sauer, and J.K. Sello. ACS Infectious Diseases, 2017. 3(2): p. 176-181. PMID[28183185].
[PubMed]. TB_03_2017.
22. Sansanmycin Natural Product Analogues as Potent and Selective Anti-mycobacterials That Inhibit Lipid I Biosynthesis. Tran, A.T., E.E. Watson, V. Pujari, T. Conroy, L.J. Dowman, A.M. Giltrap, A. Pang, W.R. Wong, R.G. Linington, S. Mahapatra, J. Saunders, S.A. Charman, N.P. West, T.D.H. Bugg, J. Tod, C.G. Dowson, D.I. Roper, D.C. Crick, W.J. Britton, and R.J. Payne. Nature Communications, 2017. 8(14414): 9pp. PMID[28248311]. PMCID[PMC5337940].
[PubMed]. TB_03_2017.
23. Isatin Hybrids and Their Anti-tuberculosis Activity. Xu, Z., S. Zhang, C. Gao, J. Fan, F. Zhao, Z.S. Lv, and L.S. Feng. Chinese Chemical Letters, 2017. 28(2): p. 159-167. ISI[000393929300001].
[WOS]. TB_03_2017.
24. Design, Synthesis and Antitubercular Evaluation of Benzothiazinones Containing an Oximido or Amino Nitrogen Heterocycle Moiety. Zhang, R., K. Lv, B. Wang, L.H. Li, B. Wang, M.L. Liu, H.Y. Guo, A.P. Wang, and Y. Lu. RSC Advances, 2017. 7(3): p. 1480-1483. ISI[000393744400037].
[WOS]. TB_03_2017.
25. Synthesis of Transition-state Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-dihydrodiol. Zhang, X.K., F. Liu, W.D. Fiers, W.M. Sun, J. Guo, Z. Liu, and C.C. Aldrich. The Journal of Organic Chemistry, 2017. 82(7): p. 3432-3440. PMID[28282140].
[PubMed]. TB_03_2017.
26. In Vitro Activity of Clarithromycin in Combination with Other Antimicrobial Agents against Mycobacterium abscessus and Mycobacterium massiliense. Zhang, Z., J. Lu, M. Liu, Y. Wang, Y. Zhao, and Y. Pang. International Journal of Antimicrobial Agents, 2017. 49(3): p. 383-386. PMID[28188830].
[PubMed]. TB_03_2017.
27. Inhibitors of Mycobacterium tuberculosis DosRST Signaling and Persistence. Zheng, H.Q., C.J. Colvin, B.K. Johnson, P.D. Kirchhoff, M. Wilson, K. Jorgensen-Muga, S.D. Larsen, and R.B. Abramovitch. Nature Chemical Biology, 2017. 13(2): p. 218-225. PMID[27992879].
[PubMed]. TB_03_2017.
28. Benzyl Amine-containing Heterocyclic Compounds and Compositions Useful against Mycobacterial Infection. Miller, M.J. and G. Moraski. Patent. 2017. 2016-US52558 2017049321: 133pp.
[Patent]. TB_03_2017.